Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Oral Contraceptive Drugs Market Growth 2022-2028

  • LP 4817839
  • 107 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Oral Contraceptive Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Oral Contraceptive Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oral Contraceptive Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Oral Contraceptive Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Contraceptive Drugs market, reaching US$ million by the year 2028. As for the Europe Oral Contraceptive Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Oral Contraceptive Drugs players cover Bayer, Pfizer, Teva Pharmaceutical, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Contraceptive Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Long-acting Contraceptives

Short-acting Contraceptives

Emergency Contraceptives

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Pharmacy

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bayer

Pfizer

Teva Pharmaceutical

Merck

Actavis

Johnson & Johnson

Gedeon Richter

Novo Nordisk A/S

ZiZhu

Baijingyu

Huazhong

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oral Contraceptive Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oral Contraceptive Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oral Contraceptive Drugs by Country/Region, 2017, 2022 & 2028

2.2 Oral Contraceptive Drugs Segment by Type

2.2.1 Long-acting Contraceptives

2.2.2 Short-acting Contraceptives

2.2.3 Emergency Contraceptives

2.3 Oral Contraceptive Drugs Sales by Type

2.3.1 Global Oral Contraceptive Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Oral Contraceptive Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oral Contraceptive Drugs Sale Price by Type (2017-2022)

2.4 Oral Contraceptive Drugs Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Other

2.5 Oral Contraceptive Drugs Sales by Application

2.5.1 Global Oral Contraceptive Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Oral Contraceptive Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oral Contraceptive Drugs Sale Price by Application (2017-2022)

3 Global Oral Contraceptive Drugs by Company

3.1 Global Oral Contraceptive Drugs Breakdown Data by Company

3.1.1 Global Oral Contraceptive Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Oral Contraceptive Drugs Sales Market Share by Company (2020-2022)

3.2 Global Oral Contraceptive Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Oral Contraceptive Drugs Revenue by Company (2020-2022)

3.2.2 Global Oral Contraceptive Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Oral Contraceptive Drugs Sale Price by Company

3.4 Key Manufacturers Oral Contraceptive Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oral Contraceptive Drugs Product Location Distribution

3.4.2 Players Oral Contraceptive Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oral Contraceptive Drugs by Geographic Region

4.1 World Historic Oral Contraceptive Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Oral Contraceptive Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oral Contraceptive Drugs Annual Revenue by Geographic Region

4.2 World Historic Oral Contraceptive Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Oral Contraceptive Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oral Contraceptive Drugs Annual Revenue by Country/Region

4.3 Americas Oral Contraceptive Drugs Sales Growth

4.4 APAC Oral Contraceptive Drugs Sales Growth

4.5 Europe Oral Contraceptive Drugs Sales Growth

4.6 Middle East & Africa Oral Contraceptive Drugs Sales Growth

5 Americas

5.1 Americas Oral Contraceptive Drugs Sales by Country

5.1.1 Americas Oral Contraceptive Drugs Sales by Country (2017-2022)

5.1.2 Americas Oral Contraceptive Drugs Revenue by Country (2017-2022)

5.2 Americas Oral Contraceptive Drugs Sales by Type

5.3 Americas Oral Contraceptive Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oral Contraceptive Drugs Sales by Region

6.1.1 APAC Oral Contraceptive Drugs Sales by Region (2017-2022)

6.1.2 APAC Oral Contraceptive Drugs Revenue by Region (2017-2022)

6.2 APAC Oral Contraceptive Drugs Sales by Type

6.3 APAC Oral Contraceptive Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oral Contraceptive Drugs by Country

7.1.1 Europe Oral Contraceptive Drugs Sales by Country (2017-2022)

7.1.2 Europe Oral Contraceptive Drugs Revenue by Country (2017-2022)

7.2 Europe Oral Contraceptive Drugs Sales by Type

7.3 Europe Oral Contraceptive Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oral Contraceptive Drugs by Country

8.1.1 Middle East & Africa Oral Contraceptive Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oral Contraceptive Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Oral Contraceptive Drugs Sales by Type

8.3 Middle East & Africa Oral Contraceptive Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oral Contraceptive Drugs

10.3 Manufacturing Process Analysis of Oral Contraceptive Drugs

10.4 Industry Chain Structure of Oral Contraceptive Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oral Contraceptive Drugs Distributors

11.3 Oral Contraceptive Drugs Customer

12 World Forecast Review for Oral Contraceptive Drugs by Geographic Region

12.1 Global Oral Contraceptive Drugs Market Size Forecast by Region

12.1.1 Global Oral Contraceptive Drugs Forecast by Region (2023-2028)

12.1.2 Global Oral Contraceptive Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oral Contraceptive Drugs Forecast by Type

12.7 Global Oral Contraceptive Drugs Forecast by Application

13 Key Players Analysis

13.1 Bayer

13.1.1 Bayer Company Information

13.1.2 Bayer Oral Contraceptive Drugs Product Offered

13.1.3 Bayer Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Main Business Overview

13.1.5 Bayer Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Oral Contraceptive Drugs Product Offered

13.2.3 Pfizer Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Teva Pharmaceutical

13.3.1 Teva Pharmaceutical Company Information

13.3.2 Teva Pharmaceutical Oral Contraceptive Drugs Product Offered

13.3.3 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Teva Pharmaceutical Main Business Overview

13.3.5 Teva Pharmaceutical Latest Developments

13.4 Merck

13.4.1 Merck Company Information

13.4.2 Merck Oral Contraceptive Drugs Product Offered

13.4.3 Merck Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck Main Business Overview

13.4.5 Merck Latest Developments

13.5 Actavis

13.5.1 Actavis Company Information

13.5.2 Actavis Oral Contraceptive Drugs Product Offered

13.5.3 Actavis Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Actavis Main Business Overview

13.5.5 Actavis Latest Developments

13.6 Johnson & Johnson

13.6.1 Johnson & Johnson Company Information

13.6.2 Johnson & Johnson Oral Contraceptive Drugs Product Offered

13.6.3 Johnson & Johnson Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Johnson & Johnson Main Business Overview

13.6.5 Johnson & Johnson Latest Developments

13.7 Gedeon Richter

13.7.1 Gedeon Richter Company Information

13.7.2 Gedeon Richter Oral Contraceptive Drugs Product Offered

13.7.3 Gedeon Richter Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Gedeon Richter Main Business Overview

13.7.5 Gedeon Richter Latest Developments

13.8 Novo Nordisk A/S

13.8.1 Novo Nordisk A/S Company Information

13.8.2 Novo Nordisk A/S Oral Contraceptive Drugs Product Offered

13.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novo Nordisk A/S Main Business Overview

13.8.5 Novo Nordisk A/S Latest Developments

13.9 ZiZhu

13.9.1 ZiZhu Company Information

13.9.2 ZiZhu Oral Contraceptive Drugs Product Offered

13.9.3 ZiZhu Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ZiZhu Main Business Overview

13.9.5 ZiZhu Latest Developments

13.10 Baijingyu

13.10.1 Baijingyu Company Information

13.10.2 Baijingyu Oral Contraceptive Drugs Product Offered

13.10.3 Baijingyu Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Baijingyu Main Business Overview

13.10.5 Baijingyu Latest Developments

13.11 Huazhong

13.11.1 Huazhong Company Information

13.11.2 Huazhong Oral Contraceptive Drugs Product Offered

13.11.3 Huazhong Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Huazhong Main Business Overview

13.11.5 Huazhong Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Oral Contraceptive Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oral Contraceptive Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Long-acting Contraceptives

Table 4. Major Players of Short-acting Contraceptives

Table 5. Major Players of Emergency Contraceptives

Table 6. Global Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)

Table 7. Global Oral Contraceptive Drugs Sales Market Share by Type (2017-2022)

Table 8. Global Oral Contraceptive Drugs Revenue by Type (2017-2022) & ($ million)

Table 9. Global Oral Contraceptive Drugs Revenue Market Share by Type (2017-2022)

Table 10. Global Oral Contraceptive Drugs Sale Price by Type (2017-2022) & (K MT)

Table 11. Global Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)

Table 12. Global Oral Contraceptive Drugs Sales Market Share by Application (2017-2022)

Table 13. Global Oral Contraceptive Drugs Revenue by Application (2017-2022)

Table 14. Global Oral Contraceptive Drugs Revenue Market Share by Application (2017-2022)

Table 15. Global Oral Contraceptive Drugs Sale Price by Application (2017-2022) & (K MT)

Table 16. Global Oral Contraceptive Drugs Sales by Company (2020-2022) & (K MT)

Table 17. Global Oral Contraceptive Drugs Sales Market Share by Company (2020-2022)

Table 18. Global Oral Contraceptive Drugs Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Oral Contraceptive Drugs Revenue Market Share by Company (2020-2022)

Table 20. Global Oral Contraceptive Drugs Sale Price by Company (2020-2022) & (K MT)

Table 21. Key Manufacturers Oral Contraceptive Drugs Producing Area Distribution and Sales Area

Table 22. Players Oral Contraceptive Drugs Products Offered

Table 23. Oral Contraceptive Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Oral Contraceptive Drugs Sales by Geographic Region (2017-2022) & (K MT)

Table 27. Global Oral Contraceptive Drugs Sales Market Share Geographic Region (2017-2022)

Table 28. Global Oral Contraceptive Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Oral Contraceptive Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Oral Contraceptive Drugs Sales by Country/Region (2017-2022) & (K MT)

Table 31. Global Oral Contraceptive Drugs Sales Market Share by Country/Region (2017-2022)

Table 32. Global Oral Contraceptive Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Oral Contraceptive Drugs Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Oral Contraceptive Drugs Sales by Country (2017-2022) & (K MT)

Table 35. Americas Oral Contraceptive Drugs Sales Market Share by Country (2017-2022)

Table 36. Americas Oral Contraceptive Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Oral Contraceptive Drugs Revenue Market Share by Country (2017-2022)

Table 38. Americas Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)

Table 39. Americas Oral Contraceptive Drugs Sales Market Share by Type (2017-2022)

Table 40. Americas Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)

Table 41. Americas Oral Contraceptive Drugs Sales Market Share by Application (2017-2022)

Table 42. APAC Oral Contraceptive Drugs Sales by Region (2017-2022) & (K MT)

Table 43. APAC Oral Contraceptive Drugs Sales Market Share by Region (2017-2022)

Table 44. APAC Oral Contraceptive Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Oral Contraceptive Drugs Revenue Market Share by Region (2017-2022)

Table 46. APAC Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)

Table 47. APAC Oral Contraceptive Drugs Sales Market Share by Type (2017-2022)

Table 48. APAC Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)

Table 49. APAC Oral Contraceptive Drugs Sales Market Share by Application (2017-2022)

Table 50. Europe Oral Contraceptive Drugs Sales by Country (2017-2022) & (K MT)

Table 51. Europe Oral Contraceptive Drugs Sales Market Share by Country (2017-2022)

Table 52. Europe Oral Contraceptive Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Oral Contraceptive Drugs Revenue Market Share by Country (2017-2022)

Table 54. Europe Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)

Table 55. Europe Oral Contraceptive Drugs Sales Market Share by Type (2017-2022)

Table 56. Europe Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)

Table 57. Europe Oral Contraceptive Drugs Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Oral Contraceptive Drugs Sales by Country (2017-2022) & (K MT)

Table 59. Middle East & Africa Oral Contraceptive Drugs Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Oral Contraceptive Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Oral Contraceptive Drugs Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)

Table 63. Middle East & Africa Oral Contraceptive Drugs Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)

Table 65. Middle East & Africa Oral Contraceptive Drugs Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Oral Contraceptive Drugs

Table 67. Key Market Challenges & Risks of Oral Contraceptive Drugs

Table 68. Key Industry Trends of Oral Contraceptive Drugs

Table 69. Oral Contraceptive Drugs Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Oral Contraceptive Drugs Distributors List

Table 72. Oral Contraceptive Drugs Customer List

Table 73. Global Oral Contraceptive Drugs Sales Forecast by Region (2023-2028) & (K MT)

Table 74. Global Oral Contraceptive Drugs Sales Market Forecast by Region

Table 75. Global Oral Contraceptive Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Oral Contraceptive Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Oral Contraceptive Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 78. Americas Oral Contraceptive Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Oral Contraceptive Drugs Sales Forecast by Region (2023-2028) & (K MT)

Table 80. APAC Oral Contraceptive Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Oral Contraceptive Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 82. Europe Oral Contraceptive Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Oral Contraceptive Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 84. Middle East & Africa Oral Contraceptive Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Oral Contraceptive Drugs Sales Forecast by Type (2023-2028) & (K MT)

Table 86. Global Oral Contraceptive Drugs Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Oral Contraceptive Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Oral Contraceptive Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Oral Contraceptive Drugs Sales Forecast by Application (2023-2028) & (K MT)

Table 90. Global Oral Contraceptive Drugs Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Oral Contraceptive Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Oral Contraceptive Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 93. Bayer Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 94. Bayer Oral Contraceptive Drugs Product Offered

Table 95. Bayer Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 96. Bayer Main Business

Table 97. Bayer Latest Developments

Table 98. Pfizer Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Pfizer Oral Contraceptive Drugs Product Offered

Table 100. Pfizer Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 101. Pfizer Main Business

Table 102. Pfizer Latest Developments

Table 103. Teva Pharmaceutical Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Teva Pharmaceutical Oral Contraceptive Drugs Product Offered

Table 105. Teva Pharmaceutical Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 106. Teva Pharmaceutical Main Business

Table 107. Teva Pharmaceutical Latest Developments

Table 108. Merck Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. Merck Oral Contraceptive Drugs Product Offered

Table 110. Merck Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 111. Merck Main Business

Table 112. Merck Latest Developments

Table 113. Actavis Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. Actavis Oral Contraceptive Drugs Product Offered

Table 115. Actavis Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 116. Actavis Main Business

Table 117. Actavis Latest Developments

Table 118. Johnson & Johnson Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 119. Johnson & Johnson Oral Contraceptive Drugs Product Offered

Table 120. Johnson & Johnson Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 121. Johnson & Johnson Main Business

Table 122. Johnson & Johnson Latest Developments

Table 123. Gedeon Richter Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 124. Gedeon Richter Oral Contraceptive Drugs Product Offered

Table 125. Gedeon Richter Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 126. Gedeon Richter Main Business

Table 127. Gedeon Richter Latest Developments

Table 128. Novo Nordisk A/S Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 129. Novo Nordisk A/S Oral Contraceptive Drugs Product Offered

Table 130. Novo Nordisk A/S Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 131. Novo Nordisk A/S Main Business

Table 132. Novo Nordisk A/S Latest Developments

Table 133. ZiZhu Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 134. ZiZhu Oral Contraceptive Drugs Product Offered

Table 135. ZiZhu Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 136. ZiZhu Main Business

Table 137. ZiZhu Latest Developments

Table 138. Baijingyu Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 139. Baijingyu Oral Contraceptive Drugs Product Offered

Table 140. Baijingyu Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 141. Baijingyu Main Business

Table 142. Baijingyu Latest Developments

Table 143. Huazhong Basic Information, Oral Contraceptive Drugs Manufacturing Base, Sales Area and Its Competitors

Table 144. Huazhong Oral Contraceptive Drugs Product Offered

Table 145. Huazhong Oral Contraceptive Drugs Sales (K MT), Revenue ($ Million), Price (K MT) and Gross Margin (2020-2022)

Table 146. Huazhong Main Business

Table 147. Huazhong Latest Developments

List of Figures

Figure 1. Picture of Oral Contraceptive Drugs

Figure 2. Oral Contraceptive Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oral Contraceptive Drugs Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Oral Contraceptive Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oral Contraceptive Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Long-acting Contraceptives

Figure 10. Product Picture of Short-acting Contraceptives

Figure 11. Product Picture of Emergency Contraceptives

Figure 12. Global Oral Contraceptive Drugs Sales Market Share by Type in 2021

Figure 13. Global Oral Contraceptive Drugs Revenue Market Share by Type (2017-2022)

Figure 14. Oral Contraceptive Drugs Consumed in Hospital

Figure 15. Global Oral Contraceptive Drugs Market: Hospital (2017-2022) & (K MT)

Figure 16. Oral Contraceptive Drugs Consumed in Pharmacy

Figure 17. Global Oral Contraceptive Drugs Market: Pharmacy (2017-2022) & (K MT)

Figure 18. Oral Contraceptive Drugs Consumed in Other

Figure 19. Global Oral Contraceptive Drugs Market: Other (2017-2022) & (K MT)

Figure 20. Global Oral Contraceptive Drugs Sales Market Share by Application (2017-2022)

Figure 21. Global Oral Contraceptive Drugs Revenue Market Share by Application in 2021

Figure 22. Oral Contraceptive Drugs Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Oral Contraceptive Drugs Revenue Market Share by Company in 2021

Figure 24. Global Oral Contraceptive Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Oral Contraceptive Drugs Revenue Market Share by Geographic Region in 2021

Figure 26. Global Oral Contraceptive Drugs Sales Market Share by Region (2017-2022)

Figure 27. Global Oral Contraceptive Drugs Revenue Market Share by Country/Region in 2021

Figure 28. Americas Oral Contraceptive Drugs Sales 2017-2022 (K MT)

Figure 29. Americas Oral Contraceptive Drugs Revenue 2017-2022 ($ Millions)

Figure 30. APAC Oral Contraceptive Drugs Sales 2017-2022 (K MT)

Figure 31. APAC Oral Contraceptive Drugs Revenue 2017-2022 ($ Millions)

Figure 32. Europe Oral Contraceptive Drugs Sales 2017-2022 (K MT)

Figure 33. Europe Oral Contraceptive Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Oral Contraceptive Drugs Sales 2017-2022 (K MT)

Figure 35. Middle East & Africa Oral Contraceptive Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Americas Oral Contraceptive Drugs Sales Market Share by Country in 2021

Figure 37. Americas Oral Contraceptive Drugs Revenue Market Share by Country in 2021

Figure 38. United States Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Oral Contraceptive Drugs Sales Market Share by Region in 2021

Figure 43. APAC Oral Contraceptive Drugs Revenue Market Share by Regions in 2021

Figure 44. China Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Oral Contraceptive Drugs Sales Market Share by Country in 2021

Figure 51. Europe Oral Contraceptive Drugs Revenue Market Share by Country in 2021

Figure 52. Germany Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Oral Contraceptive Drugs Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Oral Contraceptive Drugs Revenue Market Share by Country in 2021

Figure 59. Egypt Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Oral Contraceptive Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Oral Contraceptive Drugs in 2021

Figure 65. Manufacturing Process Analysis of Oral Contraceptive Drugs

Figure 66. Industry Chain Structure of Oral Contraceptive Drugs

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390